BioVie (BIVI) Institutional Ownership $1.03 +0.03 (+3.00%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioVie (NASDAQ:BIVI)CurrentInstitutional OwnershipPercentage4.59%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$965.81KNumber ofInstitutional Sellers(last 12 months)0 Get BIVI Insider Trade Alerts Want to know when executives and insiders are buying or selling BioVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIVI Institutional Buying and Selling by Quarter BioVie Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 NewEdge Advisors LLC54,100$53K0.0%+283.7%0.293% 2/17/2025 Squarepoint Ops LLC14,213$28K0.0%N/A0.080% 2/17/2025 Two Sigma Investments LP28,713$57K0.0%N/A0.162% 2/17/2025 Millennium Management LLC122,619$245K0.0%N/A0.690% 2/14/2025 Northern Trust Corp16,878$34K0.0%N/A0.095% 2/13/2025 NewEdge Advisors LLC14,100$28K0.0%+14,000.0%0.079% 2/13/2025 Bank of Montreal Can50,000$100K0.0%N/A0.281% 2/12/2025 Geode Capital Management LLC123,408$247K0.0%+223.3%0.694% 2/7/2025 Prosperity Wealth Management Inc.31,650$63K0.0%N/A0.178% 1/22/2025 Drive Wealth Management LLC60,000$120K0.0%N/A0.338% Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025 Sanders Morris Harris LLC40,000$85K0.0%N/A0.225% 5/14/2024 Sheaff Brock Investment Advisors LLC51,400$27K0.0%+276.9%0.129% 5/7/2024CVI Holdings LLC599,897$317K0.3%N/A1.503% 11/7/2023 Jump Financial LLC10,000$34K0.0%N/A0.027% 10/30/2023 Summit Trail Advisors LLC10,100$34K0.0%N/A0.027% 10/25/2023 Crescent Grove Advisors LLC11,000$38K0.0%N/A0.030% 10/24/2023 Bank of New York Mellon Corp15,955$54K0.0%-51.2%0.043% 8/29/2023 Garde Capital Inc.24,163$104K0.0%+40.8%0.066% 7/20/2023AJ Wealth Strategies LLC23,474$101K0.0%+52.2%0.065% 7/11/2023 FNY Investment Advisers LLC8,986$38K0.0%N/A0.025% 5/4/2023 Barclays PLC54,117$437K0.0%+117.7%0.150% 4/28/2023AJ Wealth Strategies LLC15,428$125K0.0%N/A0.043% 2/24/2023 Garde Capital Inc.17,163$133K0.0%N/A0.049% 2/14/2023 683 Capital Management LLC16,110$125K0.0%N/A0.053% 2/14/2023swisspartners Ltd.294,346$2.29M2.9%+82.8%0.964% 2/7/2023 Commonwealth Equity Services LLC12,175$94K0.0%N/A0.040% 2/1/2023 Bank of Montreal Can10,000$78K0.0%N/A0.033% 1/30/2023 International Assets Investment Management LLC10,500$82K0.0%N/A0.034% 1/10/2023 FNY Investment Advisers LLC14,200$110K0.2%N/A0.047% 11/15/2022 Pura Vida Investments LLC36,617$91K0.0%N/A0.120% 5/4/2022swisspartners Ltd.10,367$1.87M1.3%-87.1%0.042% 2/14/2022 Long Focus Capital Management LLC20,000$90K0.0%N/A0.080% 11/16/2021swisspartners Ltd.80,521$542K0.4%+45.0%0.323% 11/12/2021 Renaissance Technologies LLC53,100$355K0.0%+90.3%0.214% 8/13/2021 Renaissance Technologies LLC27,900$473K0.0%N/A0.200% 8/13/2021 Geode Capital Management LLC22,898$388K0.0%+8.0%0.164% 8/13/2021 Vanguard Group Inc.97,804$1.66M0.0%+267.6%0.700% 8/11/2021swisspartners Ltd.55,521$941K0.7%+2.2%0.397% 5/18/2021 Millennium Management LLC23,107$447K0.0%-3.7%0.166% 5/17/2021 Ameriprise Financial Inc.90,876$1.76M0.0%N/A0.651% July 2025 Rule Change to Impact Retirement Investors (Ad)There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.Yes, Send Me My FREE Retirement Guide5/12/2021 Geode Capital Management LLC21,200$410K0.0%N/A0.152% 5/12/2021swisspartners Ltd.54,300$1.05M0.9%-27.6%0.390% 5/7/2021 Sowell Financial Services LLC2,000$26K0.0%N/A0.014% (Data available from 1/1/2016 forward) BIVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIVI shares? During the previous two years, 19 institutional investors and hedge funds held shares of BioVie. The most heavily invested institutionals were CVI Holdings LLC ($317K), Geode Capital Management LLC ($247K), Millennium Management LLC ($245K), Drive Wealth Management LLC ($120K), Garde Capital Inc. ($104K), AJ Wealth Strategies LLC ($101K), and Bank of Montreal Can ($100K).Learn more on BIVI's institutional investors. What percentage of BioVie stock is owned by institutional investors? 4.59% of BioVie stock is owned by institutional investors. Learn more on BIVI's institutional investor holdings. Which institutional investors have been buying BioVie stock? Of the 18 institutional investors that purchased BioVie stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: CVI Holdings LLC ($599.90K), Millennium Management LLC ($122.62K), Geode Capital Management LLC ($85.23K), Drive Wealth Management LLC ($60K), NewEdge Advisors LLC ($54K), Bank of Montreal Can ($50K), and Sanders Morris Harris LLC ($40K). How much institutional buying is happening at BioVie? Institutional investors have bought a total of 1,196,098 shares in the last 24 months. This purchase volume represents approximately $1.51M in transactions. Which BioVie major shareholders have been selling company stock? The following institutional investors have sold BioVie stock in the last 24 months: Bank of New York Mellon Corp ($16.76K). How much institutional selling is happening at BioVie? Institutional investors have sold a total of 16,763 shares in the last 24 months. This volume of shares sold represents approximately $57.16K in transactions. Related Companies Zura Bio Institutional Ownership Cellectis Institutional Ownership Climb Bio Institutional Ownership Invizyne Technologies Institutional Ownership OncoCyte Institutional Ownership Adagene Institutional Ownership CervoMed Institutional Ownership TScan Therapeutics Institutional Ownership I-Mab Institutional Ownership Inozyme Pharma Institutional Ownership This page (NASDAQ:BIVI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.